Stockreport

OptimizeRx Q4 2023 Earnings Preview [Seeking Alpha]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF The consensus EPS Estimate is $0.26 (+4.0% Y/Y) and the consensus Revenue Estimate is $26.47M (+34.4% Y/Y).Over the last 2 years, OPRX has beaten EPS estimates 75% of t [Read more]